ING Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-47,412
Closed -$4.71M 550
2019
Q3
$4.71M Sell
47,412
-155,865
-77% -$14.8M 0.12% 126
2019
Q2
$18.8M Buy
203,277
+16,706
+9% +$1.59M 0.33% 61
2019
Q1
$17.6M Buy
186,571
+15,157
+9% +$1.33M 0.38% 52
2018
Q4
$11M Sell
171,414
-31,815
-16% -$2.35M 0.24% 74
2018
Q3
$18.2M Buy
203,229
+109,292
+116% +$9.66M 0.31% 60
2018
Q2
$7.46M Sell
93,937
-89,500
-49% -$7.43M 0.14% 90
2018
Q1
$16.4M Buy
183,437
+30,022
+20% +$2.88M 0.3% 59
2017
Q4
$16M Buy
153,415
+150,412
+5,009% +$17M 0.27% 53
2017
Q3
$438K Sell
3,003
-172,134
-98% -$23.4M 0.01% 540
2017
Q2
$22.7M Sell
175,137
-3,586
-2% -$439K 0.44% 37
2017
Q1
$22.2M Sell
178,723
-4,932
-3% -$590K 0.4% 49
2016
Q4
$21.5M Buy
183,655
+23,019
+14% +$2.56M 0.4% 51
2016
Q3
$16.5M Buy
160,636
+152,586
+1,895% +$16.5M 0.2% 71
2016
Q2
$794K Sell
8,050
-1,310
-14% -$136K 0.01% 277
2016
Q1
$937K Sell
9,360
-237,205
-96% -$24.4M 0.01% 297
2015
Q4
$29.5M Buy
246,565
+55,756
+29% +$6.45M 0.18% 138
2015
Q3
$20.6M Sell
190,809
-52,679
-22% -$6.54M 0.14% 139
2015
Q2
$28.2M Sell
243,488
-758,959
-76% -$86.8M 0.15% 140
2015
Q1
$116M Sell
1,002,447
-22,709
-2% -$2.71M 0.58% 33
2014
Q4
$115M Sell
1,025,156
-125,923
-11% -$13.3M 0.54% 33
2014
Q3
$109M Buy
1,151,079
+262,762
+30% +$23.7M 0.63% 34
2014
Q2
$76.3M Buy
888,317
+536,595
+153% +$40.8M 0.39% 54
2014
Q1
$24.6M Sell
351,722
-1,840
-0.5% -$146K 0.13% 173
2013
Q4
$29.9M Sell
353,562
-70,272
-17% -$5.56M 0.15% 154
2013
Q3
$32.7M Sell
423,834
-499,852
-54% -$35M 0.16% 141
2013
Q2
$54M Buy
+923,686
New +$55.6M 0.29% 96

Other funds holding CELG

ING Group's CELG Position: Q4 2019 in Review

ING Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 47,412 shares — an estimated $4.71M sold.

ING Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $116M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • ING Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • ING Group sold 47,412 Celgene Corp shares in Q4 2019, an estimated $4.71M.
  • ING Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • ING Group's Celgene Corp position peaked at $116M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on ING Group's 13F filing for Q4 2019, filed 10 Feb 2020.